In fact, the mechanisms for the inhibition of ER activity by AR in breast cancer are not fully understood and one suggested mechanism is direct AR binding to a subset of estrogen response elements that can prevent E2-mediated activation of ER target genes [28]. The gene discussed is AR; the disease is breast cancer.